Understanding how to improve antibiotic use in newborns
Identifying Meaningful Metrics of Neonatal Antibiotic Use
This study is looking at how antibiotics are used for newborns in NICUs to help make sure they get the right treatment and to reduce the chances of infections that don't respond to medicine, and it's for hospitals that want to improve their care for these tiny patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10911858 on NIH RePORTER |
What this research studies
This research investigates the use of antibiotics in newborn infants admitted to neonatal intensive care units (NICUs) to combat antibiotic resistance. It aims to develop a method for accurately measuring and comparing antibiotic use across different hospitals. By analyzing data from various sources, the study will create metrics that reflect the appropriateness of antibiotic use and its impact on neonatal health outcomes. This work is crucial for ensuring that newborns receive the right treatment while minimizing the risk of developing antibiotic-resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborn infants who are admitted to neonatal intensive care units and may require antibiotic treatment.
Not a fit: Patients who are not newborns or those who are not admitted to NICUs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective antibiotic use in newborns, ultimately improving their health outcomes.
How similar studies have performed: Previous research has shown success in optimizing antibiotic use in other populations, indicating that this approach may also be effective for newborns.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Flannery, Dustin Daniel — Children's Hosp of Philadelphia
- Study coordinator: Flannery, Dustin Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.